相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
Hong Sun et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2022)
Impacts of Sodium/Glucose Cotransporter-2 Inhibitors on Circulating Uric Acid Concentrations: A Systematic Review and Meta-Analysis
Abolfazl Akbari et al.
JOURNAL OF DIABETES RESEARCH (2022)
Sodium-Glucose Cotransporter-2 (SGLT-2) Attenuates Serum Uric Acid (SUA) Level in Patients with Type 2 Diabetes
Mazhar Hussain et al.
JOURNAL OF DIABETES RESEARCH (2021)
Tubular effects of sodium-glucose cotransporter 2 inhibitors: intended and unintended consequences
Jessica A. Dominguez Rieg et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2020)
Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial
Tao Yuan et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
Effects of sodium glucose cotransporter-2 inhibitors on serum uric acid in type 2 diabetes mellitus: A systematic review with an indirect comparison meta-analysis
Yakai Xin et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2019)
SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1
Aleksandra Novikov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Uric acid and cardiovascular disease
Gjin Ndrepepa
CLINICA CHIMICA ACTA (2018)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta-analysis of randomized controlled trials
Yumo Zhao et al.
DIABETES OBESITY & METABOLISM (2018)
Cardiovascular effects of urate-lowering therapies in patients with chronic gout: a systematic review and meta-analysis
Tony Zhang et al.
RHEUMATOLOGY (2017)
Serum Uric Acid Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: a Systematic Review and Meta-analysis
Shuai Yu et al.
MOLECULAR NEUROBIOLOGY (2016)
Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis
F. Zaccardi et al.
DIABETES OBESITY & METABOLISM (2016)
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Heidi Storgaard et al.
PLOS ONE (2016)
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
Yukihiro Chino et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2014)
Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Serge A. Jabbour et al.
DIABETES CARE (2014)
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
Clifford J. Bailey et al.
BMC MEDICINE (2013)
Potential Role of Uric Acid in Metabolic Syndrome, Hypertension, Kidney Injury, and Cardiovascular Diseases: Is It Time for Reappraisal?
Zohreh Soltani et al.
CURRENT HYPERTENSION REPORTS (2013)
Plasma Uric Acid Is Associated with Increased Risk of Type 2 Diabetes Independent of Diet and Metabolic Risk Factors
Ivonne Sluijs et al.
JOURNAL OF NUTRITION (2013)
High Serum Uric Acid and Increased Risk of Type 2 Diabetes: A Systemic Review and Meta-Analysis of Prospective Cohort Studies
Qin Lv et al.
PLOS ONE (2013)
Hyperuricemia as an Independent Predictor of Vascular Complications and Mortality in Type 2 Diabetes Patients: A Meta-Analysis
Yili Xu et al.
PLOS ONE (2013)
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial
K. Strojek et al.
DIABETES OBESITY & METABOLISM (2011)
Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial
Yan Miao et al.
HYPERTENSION (2011)
Cardiovascular and renal effects of hyperuricaemia and gout
F. Viazzi et al.
REUMATISMO (2011)
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level
YP Siu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
分享论文
